New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
PTSD and moral injury linked to pregnancy complications

PTSD and moral injury linked to pregnancy complications

by Tristan Horrom, Veterans Affairs Research CommunicationsCredit: CC0 Public DomainElevated symptoms of PTSD and moral injury can lead to pregnancy complications, found a Veterans Affairs study
OB & GYN April 23,2024
PTSD and moral injury linked to pregnancy complications

PTSD and moral injury linked to pregnancy complications

by Tristan Horrom, Veterans Affairs Research CommunicationsCredit: CC0 Public DomainElevated symptoms of PTSD and moral injury can lead to pregnancy complications, found a Veterans Affairs study
OB & GYN April 23,2024
SARS-CoV-2 hijacks antiviral human proteins to enter human cells

SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind
Public Health & Prevention April 22,2024
SARS-CoV-2 hijacks antiviral human proteins to enter human cells

SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind
Public Health & Prevention April 22,2024
Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

by The Francis Crick InstituteColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image
Public Health & Prevention April 22,2024
Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

by The Francis Crick InstituteColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image
Public Health & Prevention April 22,2024
Immunological memory after SARS-CoV-2 infection recovery

Immunological memory after SARS-CoV-2 infection recovery

by University of FreiburgColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu
Public Health & Prevention April 22,2024
Immunological memory after SARS-CoV-2 infection recovery

Immunological memory after SARS-CoV-2 infection recovery

by University of FreiburgColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu
Public Health & Prevention April 22,2024
How does SARS-CoV-2 evade our immune defenses?

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA
Public Health & Prevention April 22,2024
How does SARS-CoV-2 evade our immune defenses?

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA
Public Health & Prevention April 22,2024
Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

by Barcelona Institute for Global HealthColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captu
Public Health & Prevention April 22,2024
Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

by Barcelona Institute for Global HealthColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captu
Public Health & Prevention April 22,2024
S1P transporter could be crucial in the development of therapeutics for the treatment of multiple sclerosis

S1P transporter could be crucial in the development of therapeutics for the treatment of multiple sclerosis

by National University of SingaporeSpns2 deletion affects lymphocyte confinement and the vascular structures of the lymph nodes. A Representative confocal images of T cell zone (CD3-green) and B
Neurology April 22,2024
S1P transporter could be crucial in the development of therapeutics for the treatment of multiple sclerosis

S1P transporter could be crucial in the development of therapeutics for the treatment of multiple sclerosis

by National University of SingaporeSpns2 deletion affects lymphocyte confinement and the vascular structures of the lymph nodes. A Representative confocal images of T cell zone (CD3-green) and B
Neurology April 22,2024
SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

by Kelley Luckstein,Mayo ClinicThis is an illustration of a SARS-CoV-2 particle, top left. To the right of the particle, the viral genome is stretched out. Genes are represented by boxes of diff
Public Health & Prevention April 22,2024
SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

by Kelley Luckstein,Mayo ClinicThis is an illustration of a SARS-CoV-2 particle, top left. To the right of the particle, the viral genome is stretched out. Genes are represented by boxes of diff
Public Health & Prevention April 22,2024
Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

by University of BirminghamCredit: Pixabay/CC0 Public DomainPatients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the g
Public Health & Prevention April 22,2024
Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

by University of BirminghamCredit: Pixabay/CC0 Public DomainPatients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the g
Public Health & Prevention April 22,2024
SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator
Public Health & Prevention April 22,2024
SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator
Public Health & Prevention April 22,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com